These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21386628)

  • 1. Identification of prognostic and predictive markers in pancreatic adenocarcinoma. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Russo SM; Ove R; Saif MW
    JOP; 2011 Mar; 12(2):92-5. PubMed ID: 21386628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection and screening of pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Gonda TA; Saif MW
    JOP; 2011 Mar; 12(2):83-5. PubMed ID: 21386626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Chang BW; Saif MW
    JOP; 2011 Mar; 12(2):101-5. PubMed ID: 21386630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Towards the identification of new markers of pancreatic cancer by gene expression analysis].
    Rosty C
    Bull Cancer; 2004; 91(7-8):593-8. PubMed ID: 15381449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUS-guided pancreatic diagnosis and beyond. Highlights from the "2011 ASCO gastrointestinal cancers symposium". San Francisco, CA, USA. January 20-22, 2011.
    Vignesh S; Hoffe SE; Saif MW
    JOP; 2011 Mar; 12(2):86-91. PubMed ID: 21386627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer: updates on translational research and future applications.
    Sarris EG; Syrigos KN; Saif MW
    JOP; 2013 Mar; 14(2):145-8. PubMed ID: 23474558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational research in pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Strimpakos AS; Syrigos KN; Saif MW
    JOP; 2010 Mar; 11(2):124-7. PubMed ID: 20208318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the development of prognostic and predictive markers for gastrointestinal malignancies.
    Denlinger CS; Cohen SJ
    Curr Treat Options Oncol; 2007 Oct; 8(5):339-51. PubMed ID: 18193357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Kang SP; Saif MW
    JOP; 2011 Mar; 12(2):123-5. PubMed ID: 21386636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational research in pancreatic adenocarcinoma.
    Kaur G; Saif MW
    JOP; 2014 Mar; 15(2):121-3. PubMed ID: 24618433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications.
    Rodriguez JA; Li M; Yao Q; Chen C; Fisher WE
    World J Surg; 2005 Mar; 29(3):297-305. PubMed ID: 15696394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers and pharmacogenetics in pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Xu X; Strimpakos AS; Saif MW
    JOP; 2011 Jul; 12(4):325-9. PubMed ID: 21737888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
    Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
    Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
    Previdi MC; Carotenuto P; Zito D; Pandolfo R; Braconi C
    Future Oncol; 2017 Feb; 13(5):443-453. PubMed ID: 27841659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Merika E; Syrigos KN; Saif MW
    JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA-associated pancreatic cancer: the evolving management.
    Leung K; Saif MW
    JOP; 2013 Mar; 14(2):149-51. PubMed ID: 23474559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical utility of biomarkers in the management of pancreatic adenocarcinoma.
    Jazieh KA; Foote MB; Diaz LA
    Semin Radiat Oncol; 2014 Apr; 24(2):67-76. PubMed ID: 24635863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
    Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.
    Pishvaian MJ; Brody JR
    Oncology (Williston Park); 2017 Mar; 31(3):159-66, 168. PubMed ID: 28299752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational research in pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Strimpakos AS; Syrigos KN; Saif MW
    JOP; 2011 Mar; 12(2):120-2. PubMed ID: 21386635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.